FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:2208 November 22, 2007 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

(Contemporary Hematology.) Edited by Judith E. Karp. 426 pp., illustrated. Totowa, NJ, Humana Press, 2007. $149. 978-1-58829-621-4.

When I started my clinical training in hematology around 1970, the outcome of patients with acute myeloid (or myelogenous) leukemia (AML) was invariably poor. The diagnosis was based solely on morphology. As a result, it was not always possible to distinguish AML from acute lymphoblastic leukemia with confidence. Only a few textbooks about leukemias had been published, and one devoted to AML, if available, would have been a thin pamphlet. In my own library, I have a book on adult leukemias from the Cancer Treatment and Research series published by Kluwer (now Springer) in 1982. In those days, combination chemotherapy . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.